Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · IEX Real-Time Price · USD
2.020
+0.210 (11.60%)
At close: Mar 27, 2024, 4:00 PM
2.030
+0.010 (0.50%)
Pre-market: Mar 28, 2024, 8:41 AM EDT

Alterity Therapeutics Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Year 2023202220212020201920182017201620152014 2013 - 2000
Net Income
-13.81-12.85-15.31-13.46-12.34-8.27-7.54-7.73-5.89-13.33
Upgrade
Other Operating Activities
-6.230.51-2.024.03-1.622.021.680.31-4.99-0.21
Upgrade
Operating Cash Flow
-20.04-12.34-17.33-9.43-13.95-6.25-5.87-7.42-10.87-13.54
Upgrade
Capital Expenditures
-0.01-0.09-0.01-0.02-0.01-0.06-0.03-0-0.03-0.02
Upgrade
Other Investing Activities
-0.03----0.04-0-0.15-
Upgrade
Investing Cash Flow
-0.04-0.09-0.01-0.02-0.01-0.02-0.03-0-0.18-0.02
Upgrade
Share Issuance / Repurchase
0.3217.1839.244.3613.080007.1337.11
Upgrade
Debt Issued / Paid
-0.06-0.03-0.06-0.0900000-0.81
Upgrade
Other Financing Activities
-0.13-0.84-2.49-0.29-0.36-0.11-0.16--0.28-1.34
Upgrade
Financing Cash Flow
0.1216.336.693.9812.72-0.11-0.1606.8434.96
Upgrade
Exchange Rate Effect
0.912.81-0.430.260.4-0.28-0.660.954.95-0.58
Upgrade
Net Cash Flow
-19.953.8819.35-5.47-1.24-6.37-6.05-7.42-4.2121.4
Upgrade
Free Cash Flow
-20.04-12.43-17.34-9.45-13.96-6.31-5.89-7.42-10.9-13.56
Upgrade
Free Cash Flow Margin
--------5201.87%-6163.60%-3727.38%
Upgrade
Free Cash Flow Per Share
-4.95-3.10-6.13-6.33-13.60-7.09-6.62-8.34-13.01-19.00
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).